VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $22,592,304 | +46.1% | 48,200 | +30.3% | 0.01% | +40.0% |
| Q1 2024 | $15,466,370 | -15.2% | 37,000 | -17.4% | 0.01% | -16.7% |
| Q4 2023 | $18,228,672 | +9.4% | 44,800 | -6.5% | 0.01% | -20.0% |
| Q3 2023 | $16,656,746 | +3.6% | 47,900 | +4.8% | 0.02% | 0.0% |
| Q2 2023 | $16,082,287 | +18.7% | 45,700 | +6.3% | 0.02% | -6.2% |
| Q1 2023 | $13,548,010 | +11.2% | 43,000 | +1.9% | 0.02% | -15.8% |
| Q4 2022 | $12,186,516 | +43.2% | 42,200 | +43.5% | 0.02% | +72.7% |
| Q3 2022 | $8,512,000 | +79.2% | 29,400 | +61.5% | 0.01% | +120.0% |
| Q1 2022 | $4,750,000 | +89.6% | 18,200 | +71.7% | 0.01% | +66.7% |
| Q4 2020 | $2,505,000 | +243.6% | 10,600 | +140.9% | 0.00% | +50.0% |
| Q4 2018 | $729,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 40,800 | $19,123,776 | 0.07% |
| IMC-Chicago, LLC | 48,200 | $22,592,304 | 0.01% |
| SIMPLEX TRADING, LLC | 41,600 | $19,498 | 0.01% |
| JANE STREET GROUP, LLC | 56,500 | $26,482,680 | 0.01% |
| SG Americas Securities, LLC | 1,500 | $138 | 0.00% |
| JPMORGAN CHASE & CO | 31,700 | $14,858,424 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |